Sunshine Biopharma SBFM
NASDAQ SBFM
$0.18 -0.04 (-17.36%)
As of: Oct 22, 2026 · 12:54 PM EDT

Sunshine Biopharma (SBFM) Short-Term Debt issuances (2020)

Updated

Sunshine Biopharma (SBFM) reported Short-Term Debt issuances of $61,500 for FY2021, up 51.5% from $40,607 in FY2020.

Analysis

Sunshine Biopharma (SBFM) Short-Term Debt issuances (2020) Analysis & Trends

  • According to Business Quant data, Short-Term Debt issuances came in at $40,607 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn -
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn 707.00 Mn
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn -
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn -
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn -
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn -
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn -
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn -
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn -
10 Sunshine Biopharma 250,127.36 -38.84 Mn 2.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 33,607.00
Sep 30, 2020 3,000.00
API Access

Sunshine Biopharma Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=SBFM&period=max&api_key=YOUR_API_KEY